GSK faces criminal bribery investigation in Poland

* Allegations follow corruption accusations in China, Iraq * Alleged misconduct relates to promotion of lung drug (Adds GSK and CBA statements, analyst comment, more on other bribery cases) LONDON/WARSAW, April 14 (Reuters) – GlaxoSmithKline (Frankfurt: GS7.F – news) is facing a criminal investigation in Poland for allegedly bribing doctors to promote its lung drug Seretide, adding to problems …
world drug news – Yahoo News Search Results

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us